In cancer, evidence that CCR4 is known to be expressed selectively on Th2 cells and Treg cells in T-cell Lymphoma, thus, CCR4 is a good target for therapy T-Cell Lyphoma and Peripheral T-cell Lymphoma(PTCL).
Our company developed CCR4-Antibody, is a fully human monoclonal antibody, can boost up the antibody dependent cell mediated cytotoxicity(ADCC) and Complement-dependent antibody-mediated cytotoxicity (C'AMC). Thus, our CCR4-Antibody is a novel molecular target for immunotherapy of T-Cell Lyphoma and Peripheral T-cell Lymphoma(PTCL).
We would like to transfer this technology or supply CCR4-Antibody for research purpose.
More informations, please contact us.
click for larger image
Img 1
This member assumes full responsibility for the content of this listing. DIYTrade accepts no responsibility whatsoever in respect of such content.
To report fraudulent or illegal content, please
click here.
China Suppliers Quick Searching:
,
,
